Institutional investors purchased a net $3.3 million shares of DEPO during the quarter ended March 2017 and now own 93.77% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LITESPEED MANAGEMENT LLC Bought 650.7 Thousand shares of Depomed Inc
BLACKROCK FUND ADVISORS Bought 612.4 Thousand shares of Depomed Inc
THE VANGUARD GROUP, INC. Bought 609.7 Thousand shares of Depomed Inc